4.4 Article

Procoagulant Substance and Mechanism of Myristica fragrans

Journal

JOURNAL OF MEDICINAL FOOD
Volume 19, Issue 11, Pages 1065-1073

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/jmf.2016.3700

Keywords

Myristica fragrans; coagulation activity; alpha-glucosidase inhibitory activity

Funding

  1. Henan Province University Science and Technology Innovation Team [16IRTSTHN019]
  2. Industry & University Research Project in Henan Province [162107000038, 152107000051]
  3. Kaifeng City Science and Technology Innovation Talent [1509010]
  4. National cooperation project of Henan Province [2015GH12]
  5. Key project in Science and Technology Agency of Zhengzhou City [20150341]
  6. Science Research Foundation of Henan University [ZZJJ20140047]

Ask authors/readers for more resources

The effect and mechanisms of Myristica fragrans on blood clotting were evaluated by evaluating blood coagulation time and the fibrinolytic system. The compounds 2 and 5 were isolated from the herbal extract and their activities were assessed for the first time. None of the tested compounds had fibrinolytic activity, but could inhibit the fibrinolytic activity of urokinase. Compound 2 showed the highest inhibitory activity (IC50 = 1.747 mg.mL(-1)) followed by compounds 4 (IC50 = 1.818 mg.mL(-1)) and 1 (IC50 = 2.407 mg.mL(-1)), which were higher than that of the compound in Danshen drug tablets (IC50 = 6.577 mg.mL(-1)) used in China. Moreover, compounds 1 and 2 showed strong alpha-glucosidase inhibitory activity in a dose-dependent manner with IC50 values 21.76 +/- 0.59 and 21.31 +/- 0.00 mu g.mL(-1), respectively. These results demonstrated that the compounds are promising candidates as procoagulant and antidiabetic agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available